PRECISION BIOSCIENCES INC (DTIL) Corporate Subsidiaries
PRECISION BIOSCIENCES INC (DTIL) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: DTIL
CIK: 1357874
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 05/21
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerBeth Prophet-Reese
Audit LocationRaleigh, North Carolina, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-30 | 2026-09-28 | FORM 4 | 0001628280-26-063980 | View SEC Doc Filr Page |
| 4 | 2026-09-29 | 2026-09-25 | FORM 4 | 0001628280-26-063767 | View SEC Doc Filr Page |
| 4 | 2026-09-29 | 2026-09-25 | FORM 4 | 0001628280-26-063766 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-24 | — | SCHEDULE 13G/A Filing | 0002033801-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-08-24 | 2026-08-24 | 8-K | 0001628280-26-058512 | View SEC Doc Filr Page |
| S-8 | 2026-08-07 | — | S-8 | 0001628280-26-054602 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001628280-26-053837 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001628280-26-053836 | View SEC Doc Filr Page |
| 3 | 2026-08-03 | 2026-08-01 | FORM 3 | 0001628280-26-051531 | View SEC Doc Filr Page |
| 3 | 2026-08-03 | 2026-08-01 | FORM 3 | 0001628280-26-051530 | View SEC Doc Filr Page |
| 3 | 2026-08-03 | 2026-08-01 | FORM 3 | 0001628280-26-051529 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-29 | — | SCHEDULE 13G/A Filing | 0000919574-26-004663 | View SEC Doc Filr Page |
| 8-K | 2026-07-27 | 2026-07-23 | 8-K | 0001628280-26-049665 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-20 | — | SCHEDULE 13G Filing | 0000902664-26-003172 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-07-01 | 8-K | 0001628280-26-046340 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-10 | 8-K | 0001628280-26-043526 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001628280-26-041045 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001628280-26-041043 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001628280-26-041041 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001628280-26-041039 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001628280-26-041037 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | FORM 4 | 0001628280-26-040223 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | FORM 4 | 0001628280-26-040220 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | FORM 4 | 0001628280-26-040215 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | FORM 4 | 0001628280-26-040212 | View SEC Doc Filr Page |